Immune to Cancer: The CRI Blog
-
COVID-19 and Cancer Vaccines with Immunotherapy Pioneers Ugur Sahin and Özlem Türeci
Ugur Sahin and Ozlem Tureci, two of this year’s CRI Coley Award recipients, are pioneers of the…
-
COVID-19’s Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis
A new CRI report highlights the impact of the COVID-19 pandemic on cancer clinical trials compared to…
-
What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design
Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.
-
Charting the Course Ahead: CRI’s CEO Weighs in on 2020 and the Bright Path Forward
CRI CEO Jill O’Donnell-Tormey, PhD, on how the organization as well as cancer research and treatment are…
-
Cancer, COVID-19, and Vaccines: What Patients Need to Know
CRI experts share their latest insights on COVID-19 and cancer.
-
How Cancer Immunotherapy is Helping Speed a COVID-19 Vaccine
CRI Fellow Susan Klaeger, PhD, is optimizing a method to identify which antigens make the best targets…
-
CRI Scientific Leadership in Cancer and COVID-19
Members of the CRI Scientific Advisory Council are providing their immunology expertise and sharing lessons from cancer…
-
Stellar Science Solving Cancer and COVID-19
CRI Lloyd J. Old STARs are contributing to immunology work to combat COVID-19.
-
Medical Technology to Fight Cancer and COVID-19
CRI Technology Impact Award recipients are adapting technologies developed for cancer immunotherapies to understand and treat COVID-19….